Lawrence Didomenico, DPM
Podiatrist · Boardman, OHNPI 1942207733
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (48.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Linvatec Corporation at 50.2% of the total. Reporting peaked in 2022 at $606,663 and has fallen 89.8% since, to $62,163 in 2025. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 608 payments — averaging $1874.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$573K
- Musculoskeletal Transplant Foundation Inc.$216K
- Paragon 28, Inc.$71K
- Integra Lifesciences Corporation$42K
- Zimmer Biomet$41K
- Acumed LLC$33K
- plus $164K from 54 others
Across 50 payments — averaging $12,204 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Polarityte, Inc.$281K
- Geistlich Pharma, North America, Inc.$239K
- Ipsen Innovation$84K
- Musculoskeletal Transplant Foundation Inc.$8K
What the payments were for
- Consulting fees$419,82037%
- Speaking & faculty fees$87,9628%
- Grants$2,5000%
- Travel & lodging$49,2734%
- Food & beverage$25,4572%
- Education$3,3160%
- Other$551,55448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$551,554
- MEDLINE INDUSTRIES, INC.$91,848
- Product Portfolio$70,111
- ACUMED$61,872
- OsteoMed$39,191
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$29,599
- CoLink$26,579
- CERAMENTBONE VOID FILLER$26,533
- CADENCE ANKLE REPLACEMENT SYSTEM$22,601
- PANTA NAIL$22,099
- TOTAL FOOT SYSTEM$22,099
- INTEGRA WOUND MATRIX (IWM)$16,061
- CoLag$15,255
- HERCULES SUTURE ANCHOR SYSTEM$14,329
- GEISTLICH DERMA-GIDE$13,000
- IDRT$12,938
- PD-Foot&Ankle-New Product$12,914
- BILAYER WOUND MATRIX (BWM)$12,832
- FLOWABLE$12,832
- VA-LCP$12,461
How this compares
$1,139,883 in reported general payments places this provider in the 95th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 24 | $12,714 |
| Doxycycline Hyclate | 41 | $450 |
| Gabapentin | 27 | $425 |
| Mupirocin | 57 | $369 |
| Methylprednisolone | 39 | $267 |
| Ciprofloxacin Hcl | 23 | $108 |
| Tramadol Hcl | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $142 | $12,71424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 397 podiatrist providers in Ohio.
Other podiatrist in Boardman
- Mark HardyAvon$2.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
- Daniel LoganGahanna$83K
- Howard KimmelBrookpark$67K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
- Macaira DymentPowell$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.